Literature DB >> 23306382

Overexpression of the antioxidant enzyme catalase does not interfere with the glucose responsiveness of insulin-secreting INS-1E cells and rat islets.

S Lortz1, E Gurgul-Convey, O Naujok, S Lenzen.   

Abstract

AIMS/HYPOTHESIS: Hydrogen peroxide (H2O2)-inactivating enzymes such as catalase are produced in extraordinarily low levels in beta cells. Whether this low expression might be related to a signalling function of H2O2 within the beta cell is unknown. A high level of H2O2-inactivating enzymes could potentially be incompatible with glucose-induced insulin secretion. Therefore the effect of catalase overexpression on mitochondrial function and physiological insulin secretion was studied in insulin-secreting INS-1E and primary islet cells.
METHODS: INS-1E and rat islet cells were lentivirally transduced to overexpress catalase in the cytosol (CytoCat) or in mitochondria (MitoCat). Cell viability and caspase-3 activation were assessed after cytokine incubation and hypoxia. Insulin secretion was quantified and expression of the gene encoding the mitochondrial uncoupling protein 2 (Ucp2) was measured in parallel to mitochondrial membrane potential and reactive oxygen species (ROS) formation.
RESULTS: The ability to secret insulin in a glucose-dependent manner was not suppressed by catalase overexpression, although the glucose-dependent increase in the mitochondrial membrane potential was attenuated in MitoCat cells along with an increased Ucp2 expression and reduced mitochondrial ROS formation. In addition, MitoCat overexpressing cells were significantly more resistant against pro-inflammatory cytokines and hypoxia than CytoCat and control cells. CONCLUSIONS/
INTERPRETATION: The results demonstrate that an improved antioxidative defence status of insulin-secreting cells allowing efficient H2O2 inactivation is not incompatible with proper insulin secretory responsiveness to glucose stimulation and provide no support for a signalling role of H2O2 in insulin-secreting cells. Interestingly, the results also document for the first time that the decreased ROS formation with increasing glucose concentrations is of mitochondrial origin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306382     DOI: 10.1007/s00125-012-2823-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  45 in total

1.  Low revascularization of experimentally transplanted human pancreatic islets.

Authors:  Per-Ola Carlsson; Fredrik Palm; Göran Mattsson
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

Review 2.  Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes.

Authors:  A N Balamurugan; Rita Bottino; Nick Giannoukakis; Cynthia Smetanka
Journal:  Pancreas       Date:  2006-04       Impact factor: 3.327

3.  Tissue-specific disallowance of housekeeping genes: the other face of cell differentiation.

Authors:  Lieven Thorrez; Ilaria Laudadio; Katrijn Van Deun; Roel Quintens; Nico Hendrickx; Mikaela Granvik; Katleen Lemaire; Anica Schraenen; Leentje Van Lommel; Stefan Lehnert; Cristina Aguayo-Mazzucato; Rui Cheng-Xue; Patrick Gilon; Iven Van Mechelen; Susan Bonner-Weir; Frédéric Lemaigre; Frans Schuit
Journal:  Genome Res       Date:  2010-11-18       Impact factor: 9.043

Review 4.  Advancing islet transplantation: from engraftment to the immune response.

Authors:  R F Gibly; J G Graham; X Luo; W L Lowe; B J Hering; L D Shea
Journal:  Diabetologia       Date:  2011-08-10       Impact factor: 10.122

Review 5.  Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.

Authors:  Neal R Barshes; Samuel Wyllie; John A Goss
Journal:  J Leukoc Biol       Date:  2005-02-22       Impact factor: 4.962

6.  Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells.

Authors:  M Tiedge; S Lortz; J Drinkgern; S Lenzen
Journal:  Diabetes       Date:  1997-11       Impact factor: 9.461

7.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines.

Authors:  M Asfari; D Janjic; P Meda; G Li; P A Halban; C B Wollheim
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

8.  Why expression of some genes is disallowed in beta-cells.

Authors:  Roel Quintens; Nico Hendrickx; Katleen Lemaire; Frans Schuit
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

9.  Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release.

Authors:  Timo Otonkoski; Nina Kaminen; Jarkko Ustinov; Risto Lapatto; Thomas Meissner; Ertan Mayatepek; Juha Kere; Ilkka Sipilä
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion.

Authors:  Corinne Leloup; Cécile Tourrel-Cuzin; Christophe Magnan; Melis Karaca; Julien Castel; Lionel Carneiro; Anne-Laure Colombani; Alain Ktorza; Louis Casteilla; Luc Pénicaud
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more
  12 in total

1.  Metabolic activation-driven mitochondrial hyperpolarization predicts insulin secretion in human pancreatic beta-cells.

Authors:  Akos A Gerencser
Journal:  Biochim Biophys Acta Bioenerg       Date:  2018-06-08       Impact factor: 3.991

Review 2.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation.

Authors:  K Kluckova; M Sticha; J Cerny; T Mracek; L Dong; Z Drahota; E Gottlieb; J Neuzil; J Rohlena
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

4.  CXCL12 protects pancreatic β-cells from oxidative stress by a Nrf2-induced increase in catalase expression and activity.

Authors:  Svetlana Dinić; Nevena Grdović; Aleksandra Uskoković; Miloš Đorđević; Mirjana Mihailović; Jelena Arambašić Jovanović; Goran Poznanović; Melita Vidaković
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2016       Impact factor: 3.493

5.  Functional peroxisomes are required for β-cell integrity in mice.

Authors:  Ritesh Kumar Baboota; Abhijit Babaji Shinde; Katleen Lemaire; Marc Fransen; Stefan Vinckier; Paul P Van Veldhoven; Frans Schuit; Myriam Baes
Journal:  Mol Metab       Date:  2019-02-08       Impact factor: 7.422

Review 6.  To Be or Not to Be: The Divergent Action and Metabolism of Sphingosine-1 Phosphate in Pancreatic Beta-Cells in Response to Cytokines and Fatty Acids.

Authors:  Ewa Gurgul-Convey
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 7.  Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative.

Authors:  Maria de Fátima Brito; Carla Torre; Beatriz Silva-Lima
Journal:  Front Med (Lausanne)       Date:  2021-07-06

Review 8.  Update on the protective molecular pathways improving pancreatic beta-cell dysfunction.

Authors:  Alessandra Puddu; Roberta Sanguineti; François Mach; Franco Dallegri; Giorgio Luciano Viviani; Fabrizio Montecucco
Journal:  Mediators Inflamm       Date:  2013-05-02       Impact factor: 4.711

9.  Susceptibility of brown adipocytes to pro-inflammatory cytokine toxicity and reactive oxygen species.

Authors:  Lars Rebiger; Sigurd Lenzen; Ilir Mehmeti
Journal:  Biosci Rep       Date:  2016-01-21       Impact factor: 3.840

10.  Pro-inflammatory cytokines attenuate glucose-stimulated insulin secretion from INS-1E insulinoma cells by restricting mitochondrial pyruvate oxidation capacity - Novel mechanistic insight from real-time analysis of oxidative phosphorylation.

Authors:  Jonathan Barlow; Thomas P J Solomon; Charles Affourtit
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.